Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Kedzierski, Lukasz ^a,b   Linossi, Edmond M ^a,b   Kolesnik, Tatiana B ^a,b   Day, E Bridie ^b   Bird, Nicola L ^b   Kile, Benjamin T ^a,b   Belz, Gabrielle T ^a,b   Metcalf, Donald ^a,b   Nicola, Nicos A ^a,b   Kedzierska, Katherine ^b   Nicholson, Sandra E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; SOCS4 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ADAPTIVE IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL PROTECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFLAMMATION; INFLUENZA VIRUS A H1N1; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY; VIRUS LOAD;

ADAPTIVE IMMUNITY; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOPROTECTION; INFLAMMATION; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VIRAL LOAD;

EID: 84901669721     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004134     Document Type: Article

References (63)

1. Newall AT, Scuttham PA, Hodgkinson B (2007) Economic Report into the cost of influenza to the Australian Health System. http://www.influenzaspecialistgrouporgau/images/stories/docs/isg_cost_influenza_report_30_2007pdf.
2. La Gruta NL, Kedzierska K, Stambas J, Doherty PC, (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85: 85-92.
3. Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, et al. (2010) Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 5: e13099.
4. Thomas P, Keating R, Hulse-Post D, Doherty P, (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
5. Alexander WS, (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2: 410-416.
6. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci U S A 95: 114-119.
7. Feng ZP, Chandrashekaran IR, Low A, Speed TP, Nicholson SE, et al. (2012) The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5. Proteins 80: 946-957.
8. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, et al. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96: 2071-2076.
9. Linossi EM, Nicholson SE, (2012) The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life 64: 316-323.
10. Kershaw NJ, Murphy JM, Liau NP, Varghese LN, Laktyushin A, et al. (2013) SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition. Nat Struct Mol Biol 20: 469-476.
11. Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, et al. (2012) Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 36: 239-250.
12. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, et al. (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 115: 397-406.
13. Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A, (2003) CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. J Biochem 133: 109-113.
14. Lavens D, Montoye T, Piessevaux J, Zabeau L, Vandekerckhove J, et al. (2006) A complex interaction pattern of CIS and SOCS2 with the leptin receptor. J Cell Sci 119: 2214-2224.
15. Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, et al. (1999) SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98: 597-608.
16. Metcalf D, Greenhalgh CJ, Viney E, Willson TA, Starr R, et al. (2000) Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405: 1069-1073.
17. Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, et al. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20: 153-165.
18. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4: 540-545.
19. Kario E, Marmor MD, Adamsky K, Citri A, Amit I, et al. (2005) Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J Biol Chem 280: 7038-7048.
20. Bullock AN, Rodriguez MC, Debreczeni JE, Songyang Z, Knapp S, (2007) Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. Structure 15: 1493-1504.
21. Hu G, Zhou R, Liu J, Gong AY, Chen XM, (2010) MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection. J Infect Dis 202: 125-135.
22. Sasi W, Jiang WG, Sharma A, Mokbel K, (2010) Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer 10: 178.
23. Sutherland JM, Keightley RA, Nixon B, Roman SD, Robker RL, et al. (2012) Suppressor of cytokine signaling 4 (SOCS4): moderator of ovarian primordial follicle activation. J Cell Physiol 227: 1188-1198.
24. Augustin M, Sedlmeier R, Peters T, Huffstadt U, Kochmann E, et al. (2005) Efficient and fast targeted production of murine models based on ENU mutagenesis. Mamm Genome 16: 405-413.
25. Bender BS, Croghan T, Zhang L, Small PA Jr, (1992) Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175: 1143-1145.
26. Denton AE, Doherty PC, Turner SJ, La Gruta NL, (2007) IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. Eur J Immunol 37: 368-375.
27. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, et al. (2008) Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133: 235-249.
28. Peiris JS, Hui KP, Yen HL, (2010) Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol 22: 475-481.
29. Lawrence CW, Braciale TJ, (2004) Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 173: 1209-1218.
30. Lawrence CW, Ream RM, Braciale TJ, (2005) Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 174: 5332-5340.
31. Seki Y, Hayashi K, Matsumoto A, Seki N, Tsukada J, et al. (2002) Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 99: 13003-13008.
32. Pothlichet J, Chignard M, Si-Tahar M, (2008) Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 180: 2034-2038.
33. Wei H, Wang S, Chen Q, Chen Y, Chi X, et al. (2014) Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection. PLoS Pathog 10: e1003845.
34. Ramirez-Martinez G, Cruz-Lagunas A, Jimenez-Alvarez L, Espinosa E, Ortiz-Quintero B, et al. (2013) Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages. Cytokine 62: 151-159.
35. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4: e1000196.
36. Huang Y, Zaas AK, Rao A, Dobigeon N, Woolf PJ, et al. (2011) Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza A infection. PLoS Genet 7: e1002234.
37. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
38. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, et al. (2001) Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12: 171-180.
39. Paquette SG, Banner D, Zhao Z, Fang Y, Huang SS, et al. (2012) Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 7: e38214.
40. Janeway C Jr, Medzhitov R, (2000) Viral interference with IL-1 and toll signaling. Proc Natl Acad Sci U S A 97: 10682-10683.
41. Schmitz N, Kurrer M, Bachmann MF, Kopf M, (2005) Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79: 6441-6448.
42. Le JM, Fredrickson G, Reis LF, Diamantstein T, Hirano T, et al. (1988) Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci U S A 85: 8643-8647.
43. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
44. Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, et al. (2006) IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 174: 461-470.
45. Cooper AM, Khader SA, (2007) IL-12p40: an inherently agonistic cytokine. Trends Immunol 28: 33-38.
46. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523.
47. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, et al. (2013) Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 4: 1418.
48. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
49. Tough DF, Borrow P, Sprent J, (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950.
50. Di Genova G, Savelyeva N, Suchacki A, Thirdborough SM, Stevenson FK, (2010) Bystander stimulation of activated CD4+ T cells of unrelated specificity following a booster vaccination with tetanus toxoid. Eur J Immunol 40: 976-985.
51. Tajima M, Wakita D, Noguchi D, Chamoto K, Yue Z, et al. (2008) IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J Exp Med 205: 1019-1027.
52. Geginat J, Sallusto F, Lanzavecchia A, (2001) Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 194: 1711-1719.
53. Unutmaz D, Pileri P, Abrignani S, (1994) Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 180: 1159-1164.
54. Cose S, Brammer C, Khanna KM, Masopust D, Lefrancois L, (2006) Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway. Eur J Immunol 36: 1423-1433.
55. Marzio R, Mauel J, Betz-Corradin S, (1999) CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 21: 565-582.
56. Testi R, D'Ambrosio D, De Maria R, Santoni A, (1994) The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15: 479-483.
57. Smith-Garvin JE, Burns JC, Gohil M, Zou T, Kim JS, et al. (2010) T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool. Blood 116: 5548-5559.
58. Han J, Shui JW, Zhang X, Zheng B, Han S, et al. (2005) HIP-55 is important for T-cell proliferation, cytokine production, and immune responses. Mol Cell Biol 25: 6869-6878.
59. D'Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM, (2008) The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol 181: 7617-7629.
60. Rainer TH, (2002) L-selectin in health and disease. Resuscitation 52: 127-141.
61. Jenkins MR, Kedzierska K, Doherty PC, Turner SJ, (2007) Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol 179: 64-70.
62. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
63. Lee C, Kolesnik TB, Caminschi I, Chakravorty A, Carter W, et al. (2009) Suppressor of cytokine signalling 1 (SOCS1) is a physiological regulator of the asthma response. Clin Exp Allergy 39: 897-907.